Autophagy

Editing the ZKSCAN3 gene reduces nerve cell damage caused by mutant huntingtin in Huntington disease models

Updated

Abstract

A single adeno-associated virus-mediated CRISPR-Cas9 approach resulted in reduced levels of mutant huntingtin (mHTT) in animal models of Huntington disease (HD).

  • Disruption of ZKSCAN3 was achieved through CRISPR-Cas9 gene ablation in HD animal models and patient-derived stem cell models.
  • In vivo ablation of ZKSCAN3 led to improvements in behavioral symptoms and the brain environment in HD models.
  • CRISPR-Cas9-mediated ablation of ZKSCAN3 in HD patient-derived three-dimensional spheroids resulted in increased autophagy and lysosomal function.
  • ZKSCAN3-depleted neurons from HD patients exhibited reduced oxidative stress and increased lysosomal function compared to control neurons.
  • Gene expression analysis indicated heightened levels of genes involved in synaptic function and transporter activity in ZKSCAN3-edited neurons.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No potential conflict of interest was reported by the author(s).
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free